{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T20:25:02Z","timestamp":1779913502167,"version":"3.53.1"},"reference-count":30,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.3201\/eid2007.131485","type":"journal-article","created":{"date-parts":[[2014,5,27]],"date-time":"2014-05-27T14:35:14Z","timestamp":1401201314000},"source":"Crossref","is-referenced-by-count":97,"title":["Changes in Capsule and Drug Resistance of Pneumococci after Introduction of PCV7, Japan, 2010\u20132013"],"prefix":"10.3201","volume":"20","author":[{"given":"Naoko","family":"Chiba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyuki","family":"Morozumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michi","family":"Shouji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeaki","family":"Wajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimiko","family":"Ubukata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Invasive Pneumococcal Diseases Surveillance Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2007.131485-201406161346-R1","first-page":"93","article-title":"Pneumococcal conjugate vaccine for childhood immunization: WHO position paper.","volume":"82","author":"World Health Organization","year":"2007","journal-title":"Wkly Epidemiol Rec"},{"key":"key-10.3201\/eid2007.131485-201406161346-R2","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.","volume":"374","author":"O'Brien","year":"2009","journal-title":"Lancet"},{"key":"key-10.3201\/eid2007.131485-201406161346-R3","doi-asserted-by":"crossref","unstructured":"Appelbaum PC. Antimicrobial resistance inStreptococcus pneumoniae: an overview. Clin Infect Dis. 1992;15:77\u201383.PubMed10.1093\/clinids\/15.1.77","DOI":"10.1093\/clinids\/15.1.77"},{"key":"key-10.3201\/eid2007.131485-201406161346-R4","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1056\/NEJM200012283432603","article-title":"Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States.","volume":"343","author":"Whitney","year":"2000","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2007.131485-201406161346-R5","first-page":"1","article-title":"Preventing pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"49","author":"Advisory Committee on Immunization Practices","year":"2000","journal-title":"MMWR Recomm Rep"},{"key":"key-10.3201\/eid2007.131485-201406161346-R6","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Active Bacterial Core Surveillance of the Emerging Infections Program Network. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2007.131485-201406161346-R7","first-page":"893","article-title":"Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease\u2014United States, 1998\u20132003.","volume":"54","author":"Centers for Disease Control and Prevention","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid2007.131485-201406161346-R8","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1056\/NEJMoa051642","article-title":"Active Bacterial Core Surveillance of the Emerging Infections Program Network. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae.","volume":"354","author":"Kyaw","year":"2006","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2007.131485-201406161346-R9","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1056\/NEJMoa0800836","article-title":"Effect of pneumococcal conjugate vaccine on pneumococcal meningitis.","volume":"360","author":"Hsu","year":"2009","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2007.131485-201406161346-R10","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1086\/528996","article-title":"Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005.","volume":"197","author":"Moore","year":"2008","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2007.131485-201406161346-R11","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/infdis\/jir755","article-title":"Prevention of antibiotic-nonsusceptible Streptococcus pneumoniae with conjugate vaccines.","volume":"205","author":"Hampton","year":"2012","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2007.131485-201406161346-R12","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S1473-3099(11)70090-1","article-title":"Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study.","volume":"11","author":"Miller","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2007.131485-201406161346-R13","first-page":"434","article-title":"Changing epidemiology of pneumococcal serotypes after introduction of conjugate vaccine: July 2010 report.","volume":"85","author":"World Health Organization","year":"2010","journal-title":"Wkly Epidemiol Rec"},{"key":"key-10.3201\/eid2007.131485-201406161346-R14","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","article-title":"Serotype replacement in disease after pneumococcal vaccination.","volume":"378","author":"Weinberger","year":"2011","journal-title":"Lancet"},{"key":"key-10.3201\/eid2007.131485-201406161346-R15","first-page":"258","article-title":"Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children. Advisory Committee on Immunization Practices (ACIP).","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid2007.131485-201406161346-R16","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.3201\/eid1907.121830","article-title":"Pneumococcal serotypes before and after introduction of conjugate vaccines, United States, 1999\u20132011.","volume":"19","author":"Richter","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2007.131485-201406161346-R17","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/INF.0b013e318275614b","article-title":"Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine.","volume":"32","author":"Kaplan","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.3201\/eid2007.131485-201406161346-R18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/BF02350645","article-title":"Incidence of penicillin-resistant Streptococcus pneumoniae in Japan, 1993\u20131995.","volume":"1","author":"Ubukata","year":"1996","journal-title":"J Infect Chemother"},{"key":"key-10.3201\/eid2007.131485-201406161346-R19","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1128\/AAC.48.5.1488-1494.2004","article-title":"Antibiotic susceptibility in relation to penicillin-binding protein genes and serotype distribution of Streptococcus pneumoniae strains responsible for meningitis in Japan, 1999 to 2002.","volume":"48","author":"Ubukata","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2007.131485-201406161346-R20","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1089\/mdr.2012.0180","article-title":"Rapid decrease of 7-valent conjugate vaccine coverage for invasive pneumococcal diseases in pediatric patients in Japan.","volume":"19","author":"Chiba","year":"2013","journal-title":"Microb Drug Resist"},{"key":"key-10.3201\/eid2007.131485-201406161346-R21","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1089\/mdr.2011.0102","article-title":"Application of the real-time PCR method for genotypic identification of \u03b2-lactam resistance in isolates from invasive pneumococcal diseases.","volume":"18","author":"Chiba","year":"2012","journal-title":"Microb Drug Resist"},{"key":"key-10.3201\/eid2007.131485-201406161346-R22","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1093\/jac\/dki302","article-title":"Antibiotic susceptibility according to genotype of penicillin-binding protein and macrolide resistance genes, and serotype of Streptococcus pneumoniae isolates from community-acquired pneumonia in children.","volume":"56","author":"Chiba","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid2007.131485-201406161346-R23","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s10156-010-0180-3","article-title":"Molecular epidemiologic characteristics of Streptococcus pneumoniae isolates from children with meningitis in Japan from 2007 through 2009.","volume":"17","author":"Sakai","year":"2011","journal-title":"J Infect Chemother"},{"key":"key-10.3201\/eid2007.131485-201406161346-R24","doi-asserted-by":"publisher","first-page":"e197","DOI":"10.1016\/j.ijid.2009.05.010","article-title":"Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.","volume":"14","author":"Isaacman","year":"2010","journal-title":"Int J Infect Dis"},{"key":"key-10.3201\/eid2007.131485-201406161346-R25","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.3201\/eid1609.100102","article-title":"Pneumococcal serotypes in children in 4 European countries.","volume":"16","author":"Hanquet","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2007.131485-201406161346-R26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1586\/erv.10.145","article-title":"Global prevailing and emerging pediatric pneumococcal serotypes.","volume":"10","author":"McIntosh","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"key-10.3201\/eid2007.131485-201406161346-R27","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1086\/650496","article-title":"Increased penicillin nonsusceptibility of nonvaccine-serotype invasive pneumococci other than serotypes 19A and 6A in post\u20137-valent conjugate vaccine era.","volume":"201","author":"Gertz","year":"2010","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2007.131485-201406161346-R28","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1093\/cid\/cis784","article-title":"Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children.","volume":"55","author":"Okada","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2007.131485-201406161346-R29","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.ijantimicag.2013.06.022","article-title":"Associations of macrolide and fluoroquinolone resistance with molecular typing in Streptococcus pyogenes from invasive infections, 2010\u20132012.","volume":"42","author":"Wajima","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.3201\/eid2007.131485-201406161346-R30","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1371\/journal.ppat.0030168","article-title":"Vaccine escape recombinants emerge after pneumococcal vaccination in the United States.","volume":"3","author":"Brueggemann","year":"2007","journal-title":"PLoS Pathog"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/20\/7\/13-1485_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T04:27:02Z","timestamp":1733286422000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/20\/7\/13-1485_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2007.131485","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}